Conference Coverage

Alirocumab effective in homozygous FH

Publish date: March 30, 2020

 

REPORTING FROM ACC 2020

Pages

Recommended Reading

PCSK9 inhibition cuts events in very-high-risk groups
MDedge Emergency Medicine
In PAD, dropping statins ups death risk 43%
MDedge Emergency Medicine
European cholesterol guidelines push LDL targets below 55 mg/dL
MDedge Emergency Medicine
Low LDL-C and blood pressure can reduce lifetime CVD risk by 80%
MDedge Emergency Medicine
Statins cut long-term CVD risk in kids with familial hypercholesterolemia
MDedge Emergency Medicine
Treating LDL to below 70 reduces recurrent stroke
MDedge Emergency Medicine
Icosapent ethyl cost effective in REDUCE-IT analysis
MDedge Emergency Medicine
Icosapent ethyl approved for cardiovascular risk reduction
MDedge Emergency Medicine
New lipid-lowering drug earns FDA approval
MDedge Emergency Medicine
Lipidologists welcome bempedoic acid as new lipid-lowering option
MDedge Emergency Medicine